Questex - Latest Emails, Sales & Deals| 03.28.24 | GSK anemia rival nabs FDA nod; Novo, Lilly face GLP-1 price pushbackMarch 28, 2024 - 14 hours ago| 03.28.24 | Gilead pays $43M+ for Xilio’s early IL-12 prospect; Moderna surfs 3rd vaccine wave with ph. 1 datasetsMarch 28, 2024 - 15 hours agoAOF nutrition for T cellsMarch 28, 2024 - 16 hours ago| 03.28.24 | FDA should inspect investigator hiring practices: GAO; Veeda enters international marketsMarch 28, 2024 - 16 hours ago| 03.27.24 | BMS takes ax to Mirati after $5.8B buyout; Blackstone bets $750M on Moderna flu shot; #FierceMadness marches onMarch 27, 2024 - 1 day ago| 03.27.24 | Bristol Myers axes 250+ staffers after Mirati buyout; Bayer layoffs hit US headquarters; Merck scores key FDA nodMarch 27, 2024 - 1 day ago| 03.27.24 | Moderna turns over Blackstone for $750M flu program support; #FierceMadness Round of 32 resultsMarch 27, 2024 - 1 day ago| 03.27.24 | FDA to ban electroshock devices, again; Masimo to split off consumer businessMarch 27, 2024 - 1 day ago| 03.27.24 | Walter the Dino helps AstraZeneca push home its modern message; Regeneron looks to the stars for Eylea campaignMarch 27, 2024 - 1 day agoLeveraging Real-World Evidence for orphan drug access in EuropeMarch 27, 2024 - 1 day agoGet Your First Look at the 2024 Agenda!March 27, 2024 - 1 day agoProtect your advanced therapies with our comprehensive cold chain capabilitiesMarch 27, 2024 - 1 day ago| 03.26.24 | Lilly CEO sees major pay boost; Bluebird reveals accounting errorsMarch 26, 2024 - 2 days ago| 03.26.24 | Moderna’s next-gen COVID vax supersedes approved shot; Nanoscope gene therapy restores visionMarch 26, 2024 - 2 days agoUnlock the Power of Omnichannel Communication in Medical AffairsMarch 26, 2024 - 2 days ago| 03.26.24 | Theratechnologies to cut preclinical oncology program; Mouth microbe drives colorectal cancerMarch 26, 2024 - 2 days ago| 03.26.24 | Catalent lays off 130 before Novo sale; MilliporeSigma drops €300M on Korean biologics plantMarch 26, 2024 - 2 days ago[Case Study] Improve Timelines with Site InsightsMarch 26, 2024 - 2 days agoUnlock the True Potential of Your DataMarch 26, 2024 - 2 days ago| 03.25.24 | Novo Nordisk pumped for $1B Cardior buyout; Lilly CEO reaps 24% pay boost; #FierceMadness round 2 is openMarch 25, 2024 - 3 days ago| 03.25.24 | BD ups US production as FDA warns against syringes from China; Researchers deliver antibody-generating AIMarch 25, 2024 - 3 days ago| 03.25.24 | J&J nabs approval for PAH combo tablet as AstraZeneca grows Ultomiris' label; FTC blasts Teva's patents—againMarch 25, 2024 - 3 days ago| 03.25.24 | Novo Nordisk boosts heart failure plans with $1B Cardior buy; Regeneron’s blood cancer med hits FDA snagMarch 25, 2024 - 3 days agoSay Goodbye to Cookies: Unlock Omnichannel SuccessMarch 25, 2024 - 3 days ago| 03.25.24 | You get free marketing! Oprah plugs GLP-1s in TV special; Merck’s Keytruda claims digital marketing crownMarch 25, 2024 - 3 days ago| 03.22.24 | GSK sends some Bellus staff packing; New DMD approval tees up Sarepta showdownMarch 22, 2024 - 6 days ago| 03.22.24 | FDA's new Duchenne approval tees up Sarepta market clash; Bristol CEO nets nearly $20M in final yearMarch 22, 2024 - 6 days ago| 03.22.24 | Who has the best biotech name? Round 1 results are in; Nkarta's blood cancer CAR stalls out of raceMarch 22, 2024 - 6 days ago| 03.22.24 | The top pharma R&D spenders; The new obesity R&D landscape; Lonza's mammoth $1.2B roche plant dealMarch 22, 2024 - 6 days ago| 03.22.24 | The clock’s TikToking as pharma must be more agile on social media; Moderna taps long COVID concerns in new vax campaignMarch 22, 2024 - 6 days agoCMS Health Equity Index: New Measure, New IdeasMarch 21, 2024 - 7 days ago| 03.21.24 | Idorsia's Tryvio, after buyback from J&J, crosses FDA finish line; Boundless Bio weighs $88M offering as IPOs open upMarch 21, 2024 - 7 days agoUnlock Social Media for PharmaMarch 21, 2024 - 7 days ago| 03.21.24 | Bayer's overhaul begins to take shape; Merck's Lynparza-Keytruda combo fails another trialMarch 21, 2024 - 7 days ago| 03.21.24 | Prometheus team is back with $400M and a new biotech; Innate shelves one of their lymphoma programsMarch 21, 2024 - 7 days ago| 03.21.24 | Lonza inks $1.2B deal to buy Roche biologics campus; Novo Nordisk plots $560M expansion in ChinaMarch 21, 2024 - 7 days agoArticle: Microsampling innovations for improved patient care and treatmentMarch 21, 2024 - 7 days ago| 03.21.24 | Lilly urges sponsors to embrace community-based trials; Parexel CEO hands over reinsMarch 21, 2024 - 7 days agoSurvey uncovers insourcing trends for patient hubsMarch 21, 2024 - 7 days ago| 03.20.24 | #FierceMadness returns: Vote on the best biotech, drug names; Orchard's $4.25M gene therapy is world's priciest medMarch 20, 2024 - 8 days agoThe latest strategies shaping liver disease research...March 20, 2024 - 8 days ago| 03.20.24 | J&J taps Nvidia for surgery AI; Montagu carves out Johnson Matthey's medtech metals unit for $700MMarch 20, 2024 - 8 days ago| 03.20.24 | Roche sells massive site to Lonza amid CDMO industry upheaval; Bristol Myers again eyes first-line liver cancerMarch 20, 2024 - 8 days ago| 03.20.24 | Novo Holdings-backed biotech Clasps $150M for next-gen cancer tech; Acelyrin's comeback picks up speedMarch 20, 2024 - 8 days agoWebinar – Launch Excellence, U.S. Edition: Rewriting the PlaybookMarch 20, 2024 - 8 days ago| 03.20.24 | Fierce Madness is back! Get voting in the 2024 drug name tournament; Exact Sciences taps Ex-NBA star for cancer campaignMarch 20, 2024 - 8 days ago| 03.19.24 | The obesity era: 124 assets and beyond; Gilead boosts CEO pay to $22.6MMarch 19, 2024 - 9 days ago| 03.19.24 | AbbVie CEO, headed for the exit, nets another big payday; Novo Nordisk ups its ante in ChinaMarch 19, 2024 - 9 days ago| 03.19.24 | AstraZeneca hears Radio Ga Ga in $2B Fusion deal; Bayer’s Astellas rival dims hot flashesMarch 19, 2024 - 9 days ago| 03.19.24 | Tenaya cardiac gene therapy boosts survival in mice; Protease inhibitor bests Paxlovid in mouse lungsMarch 19, 2024 - 9 days ago| 03.19.24 | Novartis commits $256M for Singapore expansion, plots 100 hires; EuroAPI flags quality shortfalls, suspends guidanceMarch 19, 2024 - 9 days agoSay Goodbye to RPM Headaches: Discover UnityMarch 19, 2024 - 9 days agoNew research report reveals pharmacovigilance is changingMarch 19, 2024 - 9 days agoUncover patient feedback with AI to improve brand performanceMarch 19, 2024 - 9 days agoMarken | Biological Sample Logistics. RevolutionizedMarch 19, 2024 - 9 days ago| 03.18.24 | Top 10 pharma R&D budgets for ’23; J&J-partnered biotech files latest IPOMarch 18, 2024 - 10 days ago| 03.18.24 | Better Therapeutics shutters operations, lays off staff; Titan Medical finds new home with ConaviMarch 18, 2024 - 10 days ago| 03.18.24 | AZ, GSK tout immunotherapy uses in endometrial cancer; FDA advisers support Carvykti, Abecma in earlier myelomaMarch 18, 2024 - 10 days agoEarly Bird Rate Ends Friday | Only 15 Passes Left at This RateMarch 18, 2024 - 10 days ago| 03.18.24 | Merck tops list of highest R&D spenders; Orchard snags FDA nod for 1st MLD gene therapyMarch 18, 2024 - 10 days agoNavigating sensitive situations: exclusive insights from DSMB expertsMarch 18, 2024 - 10 days ago| 03.18.24 | GSK doubles down on vaccination push; UCB unveils first-ever ad work at the OscarsMarch 18, 2024 - 10 days agoGrow in North Carolina: A Leader in BiomanufacturingMarch 15, 2024 - 13 days ago| 03.15.24 | J&J, Legend win over FDA advisers in Carvykti expansion bid; Moderna won't advance Zika shot without more cashMarch 15, 2024 - 13 days ago| 03.15.24 | BMS, Madrigal, BeiGene ride FDA approval wave; Merck’s Keytruda shows survival benefit in cervical cancerMarch 15, 2024 - 13 days ago| 03.15.24 | Moderna won't advance Zika vax without more cash; Madrigal makes MASH history. What's next?March 15, 2024 - 13 days ago| 03.15.24 | The top 10 drugs losing US exclusivity; Wegovy wins cardio risk nod; Merck clutches Pearl with $1B betMarch 15, 2024 - 13 days ago| 03.15.24 | Sun Pharma taps Dr. Pimple Popper for new spot; Merz teams with Demi Lovato in latest campaign for Botox rivalMarch 15, 2024 - 13 days ago| 03.14.24 | AstraZeneca makes $800M bet in endocrinology; BIO bounces WuXi AppTec over Chinese government tiesMarch 14, 2024 - 14 days agoBREAKING: First MASH drug approved by the FDAMarch 14, 2024 - 14 days agoUnlock the Power of Video in Pharma CommunicationsMarch 14, 2024 - 14 days ago| 03.14.24 | BIO severs ties with WuXi over BIOSECURE Act; NICE wants more data from CRISPR therapy Casgevy in unusual rulingMarch 14, 2024 - 14 days ago| 03.14.24 | AZ snatches late-stage rare disease drug in $800M Amolyt deal; Genmab to wield 'pretty good buying power'March 14, 2024 - 14 days ago20 years of recombinant antibody innovationMarch 14, 2024 - 14 days ago| 03.14.24 | Takeda winds down Austrian site, plots 190 layoffs; Charles River inks new gene therapy production pactMarch 14, 2024 - 14 days ago| 03.14.24 | Fortrea becomes 'pure-play' CRO after asset sale; TFS hops into AustraliaMarch 14, 2024 - 14 days agoGet the latest trends in clinical research and digital technologies by HLTHMarch 14, 2024 - 14 days agoCMI Media Group Expands Global OpportunitiesMarch 14, 2024 - 14 days ago| 03.13.24 | Top J&J execs Duato, Reed rocket past competitor pay; Galderma gears up for long-awaited $2.6B IPOMarch 13, 2024 - 15 days ago| 03.13.24 | Ionis joins MASH-up with phase 2 data; 70k ‘trip reports’ later, AI-derived psychedelic to enter human testsMarch 13, 2024 - 15 days ago| 03.13.24 | Medtronic's Frank Chan on its reborn patient monitoring division; Patient Square places $220M bid for NanoString assetsMarch 13, 2024 - 15 days agoDCAT 2024 Preview IssueMarch 13, 2024 - 15 days agoAnalytical Strategies to Bolster Your BiologicMarch 13, 2024 - 15 days agoDon’t Miss This Premiere Cell and Gene Therapy EventMarch 13, 2024 - 15 days ago| 03.13.24 | Lilly uses the Oscars for broadside against GLP-1 misuse; Incyte draws on AI art for MPN initiativeMarch 13, 2024 - 15 days ago| 03.12.24 | Moderna CEO’s pay slips 5%; Geron faces uphill battle at FDA adcommMarch 12, 2024 - 16 days agoCelebrating 20 Years with New Tracks, Interactive Roundtables, Fun Activities and More!March 12, 2024 - 16 days ago| 03.12.24 | Insilico 'pulls back curtain' on AI drug discovery; Glioblastoma therapy extends survival in early dataMarch 12, 2024 - 16 days ago| 03.12.24 | Pfizer looks to grow Adcetris' reach after trial win; Moderna CEO sees 5% drop in total payMarch 12, 2024 - 16 days ago| 03.12.24 | Merck clutches Pearl's 'smart' biologics for up to $1B; Lilly launches into space—againMarch 12, 2024 - 16 days ago1...3456789101112131415161718LatestFind More Emails, Deals & Sales From These StoresOLGEgenciaOSEA MalibuMOJO EuropeBali BodyFormula EssentialsBelly LoveShort Par 4Schaefer OutfitterSunshine StateReligion News ServiceTANacious TanningSaturday Morning PancakesState Line TackAvani & CoPalm Beach Jewelrytaste.com.auGreens SteelChemical GuysSmiths City